Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 3NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 27Neoplasms 9Kidney Neoplasms 9Carcinoma, Non-Small-Cell Lung 8Carcinoma 7Lung Neoplasms 4Carcinoma, Hepatocellular 4Neoplasm Metastasis 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Stomach Neoplasms 2Solid Tumors 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Ovarian Neoplasms 2Melanoma 2Kidney Diseases 2Advanced Solid Tumors 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Urinary Bladder Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Pancreatic Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, Mantle-Cell 1Liver Diseases 1Leukemia, Myeloid, Acute 1Glioblastoma 1

Interventions

Sunitinib 4Ipilimumab 3pazopanib 2fludarabine 2Nivolumab 2cabozantinib 1atezolizumab 1Specimen Handling 1Magnetic Resonance Spectroscopy 1LY2510924 1Cyclophosphamide 1CTLA-4 Antigen 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Clear-cell metastatic renal cell carcinoma × Axitinib × Clear all
NCT07227415 2026-06-04

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Pfizer

Phase 1/2 Recruiting
224 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡